Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Klatskin Tumor × temoporfin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Squamous Cell Carcinoma of Head and Neck 2 Head and Neck Neoplasms 2 Salivary Gland Neoplasms 1 Recurrence 1 Neoplasms 1 Nasopharyngeal Carcinoma 1 Klatskin Tumor 1 Cholangiocarcinoma 1 Carcinoma, Squamous Cell 1

Interventions

Fluorouracil 3 Capecitabine 3 toripalimab 2 Oxaliplatin 2 tremelimumab 1 trametinib 1 tislelizumab 1 temoporfin 1 sacituzumab govitecan 1 lenvatinib 1 gemcitabine-oxaliplatin regimen 1 durvalumab 1 dehydroftorafur 1 Stents 1 Specimen Handling 1 Sorafenib 1 Radiosurgery 1 Magnetic Resonance Spectroscopy 1 Leucovorin 1 Hydroxychloroquine 1 Gemcitabine 1 Erlotinib Hydrochloride 1 Cisplatin 1 Biopsy 1 3-(4-chlorophenyl)-adamantane-1-carboxylic acid (pyridin-4-ylmethyl)amide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03003065 2023-08-22

PDT

Chinese University of Hong Kong

Phase 2 Completed

Gastrointestinal

Neoplasms, Cholangiocarcinoma, Klatskin Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡